1.  If a system for the reporting of information on neurodegenerative diseases is established pursuant to NRS 439.5268, the designated department shall prescribe a form which provides a patient with:

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

(a) Written notice concerning the collection of information pursuant to NRS 439.5252 to 439.5284, inclusive, and the purposes for which such information is collected; and

(b) The opportunity to opt in to the collection of such information by executing the form.

2.  If a system for the reporting of information on neurodegenerative diseases is established pursuant to NRS 439.5268, a hospital, medical laboratory or other facility that provides screening, diagnostic or therapeutic services to patients with respect to neurodegenerative diseases or a provider of health care who diagnoses or provides treatment for neurodegenerative diseases may provide to a patient with a neurodegenerative disease for which reporting is authorized pursuant to NRS 439.5272:

(a) Oral notice concerning the collection of information pursuant to NRS 439.5252 to 439.5284, inclusive, and the purpose for which such information is collected; and

(b) A copy of the form prescribed pursuant to subsection 1.

3.  If a patient:

(a) Executes the form provided to the patient pursuant to subsection 2, the hospital, medical laboratory, other facility or provider of health care, as applicable, may report information concerning the patient to the system established pursuant to NRS 439.5268.

(b) Does not execute the form provided to the patient pursuant to subsection 2, the hospital, medical laboratory, other facility or provider of health care, as applicable, shall not report any information concerning the patient to the system established pursuant to NRS 439.5268.

4.  As used in this section, ‘medical laboratory’ has the meaning ascribed to it in NRS 652.060.